Associated Papers
Identification of diagnostic and prognostic genetic alterations in uveal melanoma using RNA sequencing.
Nell RJ et al.
Scientific Reports, 2025
40059100 (PubMed )
Supplement: 41598_2025_90122_MOESM2_ESM.xlsx › Supplementary_Table_2
Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.
Yu L et al.
Molecular Oncology, 2022
34706158 (PubMed )
Supplement: MOL2-16-607-s006.xls › TCGA_UM_dataset
Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers.
Boot A et al.
Proceedings of the National Academy of Sciences of the United States of America, 2022
35058360 (PubMed )
Supplement: pnas.2114024119.sd08.xlsx › Dataset.S8
Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies.
Yan YC et al.
Journal of Cancer, 2022
Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
Akin-Bali DF
Ophthalmic Genetics, 2021
Select a paper to view details